The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Aerodiol     (8S,9S,13S,14S,17S)-13- methyl-6,7,8,9,11...

Synonyms: Estrace, Ovocyclin, Vivelle, estradiol, Oestradiol, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Ovocyclin

  • Estrogen replacement therapy in patients with endometrial cancer: a survey of prescription intention of Belgian gynecologists [1].
  • Estrogen receptors, breast cancer, and smoking [2].
  • Bile cholesterol saturation correlated with obesity (r = 0.41; P less than 0.001) and urinary estrogen excretion (r = 0.44; P less than 0.001) [3].
  • BACKGROUND: Estrogen-replacement therapy prevents osteoporosis in postmenopausal women by inhibiting bone resorption, but the balance between its long-term risks and benefits remains unclear [4].
  • Finally, this investigation contradicts the speculation that the association between this cancer and estrogen use can be explained by swifter diagnosis for estrogen users, misclassification of estrogen-related hyperplasia or treatment of early symptoms of the tumor with estrogen [5].
  • Estradiol treatment reduced weight gain and increased atrial ANP synthesis as well as decreased ANP clearance NPR-C receptors, resulting in elevation of circulating ANP level [6].

Psychiatry related information on Ovocyclin


High impact information on Ovocyclin


Chemical compound and disease context of Ovocyclin


Biological context of Ovocyclin


Anatomical context of Ovocyclin

  • The induction of the 46K secreted protein(s) makes these cell lines excellent in vitro systems for studying the mechanism of estrogen and anti-estrogen action [25].
  • We conclude that many estrogen preparations subject the endometrium to a potent stimulus [26].
  • Growth and function of primary cultures of granulosa cells obtained from immature, hypophysectomized, estrogen-treated rats were compared in serum-containing and serum-free media [27].
  • Quantitation of elongating form A and B RNA polymerases in chick oviduct nuclei and effects of estradiol [28].
  • Furthermore, neither normal human nor CF fibroblasts could be demonstrated to contain detectable receptor activity for 3H-17 beta-estradiol [29].

Associations of Ovocyclin with other chemical compounds


Gene context of Ovocyclin

  • We show here a novel role for cyclin D1 in growth regulation of estrogen-responsive tissues by potentiating transcription of estrogen receptor-regulated genes [24].
  • Here we report that estradiol (E2) triggers a robust increase in the number of excitatory inputs to POMC neurons in the arcuate nucleus of wild-type rats and mice [36].
  • However, estrogen-induced decrease in body weight was dependent on Stat3 activation in the brain [36].
  • These results raise the possibility that wild-type BRCA1 suppresses estrogen-dependent transcriptional pathways related to mammary epithelial cell proliferation and that loss of this ability contributes to tumorigenesis [37].
  • AIB1 protein interacted with estrogen receptors in a ligand-dependent fashion, and transfection of AIB1 resulted in enhancement of estrogen-dependent transcription [38].
  • These large-scale studies of elderly men and women indicate that the ERalpha cofactor RIZ gene has a prominent effect on BMD, and the P704 genotype modulates the impact of estradiol on BMD [39].
  • Experiments with bone marrow cells from ER-deficient mice and the ER antagonist ICI182,780 showed that estradiol acted primarily via ERalpha to regulate DC differentiation [40].
  • In men, significant associations were detected between CYP19A1 polymorphisms and estradiol and testosterone levels, and the estradiol to testosterone ratio (P ranges 0.0005-0.01) [41].

Analytical, diagnostic and therapeutic context of Ovocyclin

  • We compared 14 women who had undergone oophorectomy during young adulthood, 14 normal perimenopausal women, and 14 normal postmenopausal women (mean ages, 54, 52, and 73 years, respectively; mean duration of estrogen deficiency, 22, 0.3, and 22 years, respectively) [42].
  • Radioimmunoassay confirmed a lower mean estradiol concentration (amenorrheic group, 38.58 pg per milliliter; eumenorrheic group, 106.99 pg per milliliter) and progesterone peak (amenorrheic group, 1.25 ng per milliliter; eumenorrheic group, 12.75 ng per milliliter) in the amenorrheic women, in four venous samples drawn at seven-day intervals [43].
  • Vitellogenin gene expression in male Xenopus hepatocytes during primary and secondary stimulation with estrogen in cell cultures [44].
  • In the receptor-rich group, the survival of the 21 patients receiving combined therapy was significantly longer than that of 19 patients receiving estrogen as initial therapy (followed by chemotherapy after failure or relapse) [45].
  • METHODS: We compared the sensitivity and specificity of transvaginal ultrasonography and endometrial biopsy for the detection of endometrial disease in 448 postmenopausal women who received estrogen alone, cyclic or continuous estrogen-progesterone, or placebo for three years [46].


  1. Estrogen replacement therapy in patients with endometrial cancer: a survey of prescription intention of Belgian gynecologists. Rozenberg, S., Vasquez, J.B. CA: a cancer journal for clinicians. (1999) [Pubmed]
  2. Estrogen receptors, breast cancer, and smoking. Daniell, H.W. N. Engl. J. Med. (1980) [Pubmed]
  3. Development of lithogenic bile during puberty in Pima indians. Bennion, L.J., Knowler, W.C., Mott, D.M., Spagnola, A.M., Bennett, P.H. N. Engl. J. Med. (1979) [Pubmed]
  4. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. Hosking, D., Chilvers, C.E., Christiansen, C., Ravn, P., Wasnich, R., Ross, P., McClung, M., Balske, A., Thompson, D., Daley, M., Yates, A.J. N. Engl. J. Med. (1998) [Pubmed]
  5. Endometrial cancer and estrogen use. Report of a large case-control study. Antunes, C.M., Strolley, P.D., Rosenshein, N.B., Davies, J.L., Tonascia, J.A., Brown, C., Burnett, L., Rutledge, A., Pokempner, M., Garcia, R. N. Engl. J. Med. (1979) [Pubmed]
  6. Impairment of the natriuretic peptide system in follitropin receptor knockout mice and reversal by estradiol: implications for obesity-associated hypertension in menopause. Belo, N.O., Sairam, M.R., Dos Reis, A.M. Endocrinology (2008) [Pubmed]
  7. Osteoporosis in women with anorexia nervosa. Rigotti, N.A., Nussbaum, S.R., Herzog, D.B., Neer, R.M. N. Engl. J. Med. (1984) [Pubmed]
  8. Vaginal stimulation: an important determinant of maternal bonding in sheep. Keverne, E.B., Levy, F., Poindron, P., Lindsay, D.R. Science (1983) [Pubmed]
  9. Ejaculatory pattern in female rats without androgen treatment. Emery, D.E., Sachs, B.D. Science (1975) [Pubmed]
  10. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. Mulnard, R.A., Cotman, C.W., Kawas, C., van Dyck, C.H., Sano, M., Doody, R., Koss, E., Pfeiffer, E., Jin, S., Gamst, A., Grundman, M., Thomas, R., Thal, L.J. JAMA (2000) [Pubmed]
  11. Mechanisms controlling the function and life span of the corpus luteum. Niswender, G.D., Juengel, J.L., Silva, P.J., Rollyson, M.K., McIntush, E.W. Physiol. Rev. (2000) [Pubmed]
  12. Luteolysis: a neuroendocrine-mediated event. McCracken, J.A., Custer, E.E., Lamsa, J.C. Physiol. Rev. (1999) [Pubmed]
  13. Genome-wide analysis of estrogen receptor binding sites. Carroll, J.S., Meyer, C.A., Song, J., Li, W., Geistlinger, T.R., Eeckhoute, J., Brodsky, A.S., Keeton, E.K., Fertuck, K.C., Hall, G.F., Wang, Q., Bekiranov, S., Sementchenko, V., Fox, E.A., Silver, P.A., Gingeras, T.R., Liu, X.S., Brown, M. Nat. Genet. (2006) [Pubmed]
  14. Time of implantation of the conceptus and loss of pregnancy. Wilcox, A.J., Baird, D.D., Weinberg, C.R. N. Engl. J. Med. (1999) [Pubmed]
  15. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. Darling, G.M., Johns, J.A., McCloud, P.I., Davis, S.R. N. Engl. J. Med. (1997) [Pubmed]
  16. Peptide antagonists of the human estrogen receptor. Norris, J.D., Paige, L.A., Christensen, D.J., Chang, C.Y., Huacani, M.R., Fan, D., Hamilton, P.T., Fowlkes, D.M., McDonnell, D.P. Science (1999) [Pubmed]
  17. Estradiol shortens the period of hamster circadian rhythms. Morin, L.P., Fitzgerald, K.M., Zucker, I. Science (1977) [Pubmed]
  18. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. LeBoff, M.S., Kohlmeier, L., Hurwitz, S., Franklin, J., Wright, J., Glowacki, J. JAMA (1999) [Pubmed]
  19. The role of insulin-like growth factor-I and growth factor-associated signal transduction pathways in estradiol and progesterone facilitation of female reproductive behaviors. Etgen, A.M., Gonz??lez-Flores, O., Todd, B.J. Frontiers in neuroendocrinology (2006) [Pubmed]
  20. Opposing effects of runx2 and estradiol on breast cancer cell proliferation: in vitro identification of reciprocally regulated gene signature related to clinical letrozole responsiveness. Chimge, N.O., Baniwal, S.K., Luo, J., Coetzee, S., Khalid, O., Berman, B.P., Tripathy, D., Ellis, M.J., Frenkel, B. Clin. Cancer Res. (2012) [Pubmed]
  21. An estrogen receptor from Xenopus laevis liver possibly connected with vitellogenin synthesis. Westley, B., Knowland, J. Cell (1978) [Pubmed]
  22. Editorial: Cancer risk and estrogen use in the menopause. Ryan, K.J. N. Engl. J. Med. (1975) [Pubmed]
  23. Dehydroepiandrosterone sulfate loading test in the diagnosis of complicated pregnancies. Tulchinsky, D., Osathanondh, R., Finn, A. N. Engl. J. Med. (1976) [Pubmed]
  24. CDK-independent activation of estrogen receptor by cyclin D1. Zwijsen, R.M., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., Michalides, R.J. Cell (1997) [Pubmed]
  25. A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Westley, B., Rochefort, H. Cell (1980) [Pubmed]
  26. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. Whitehead, M.I., Townsend, P.T., Pryse-Davies, J., Ryder, T.A., King, R.J. N. Engl. J. Med. (1981) [Pubmed]
  27. Serum suppresses the expression of hormonally induced functions in cultured granulosa cells. Orly, J., Sato, G., Erickson, G.F. Cell (1980) [Pubmed]
  28. Quantitation of elongating form A and B RNA polymerases in chick oviduct nuclei and effects of estradiol. Cox, R.F. Cell (1976) [Pubmed]
  29. Dexamethasone-resistant cystic fibrosis fibroblasts show cross-resistance to sex steroids. Breslow, J.L., Epstein, J., Fontaine, J.H. Cell (1978) [Pubmed]
  30. Direct induction by estradiol on vitellogenin synthesis in organ cultures of male Xenopus laevis liver. Green, C.D., Tata, J.R. Cell (1976) [Pubmed]
  31. The interaction of estradiol-receptor protein with the genome: an argument for the existence of undetected specific sites. Yamamoto, K., Alberts, B. Cell (1975) [Pubmed]
  32. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. Wahl, P., Walden, C., Knopp, R., Hoover, J., Wallace, R., Heiss, G., Rifkind, B. N. Engl. J. Med. (1983) [Pubmed]
  33. Androgen-dependent fibrinolytic activity in a murine mammary carcinoma (Shionogi SC-115 cells) in vitro. Mak, T.W., Rutledge, G., Sutherland, D.J. Cell (1976) [Pubmed]
  34. The endogenous estradiol metabolite 2-methoxyestradiol reduces atherosclerotic lesion formation in female apolipoprotein E-deficient mice. Bourghardt, J., Bergström, G., Krettek, A., Sjöberg, S., Borén, J., Tivesten, A. Endocrinology (2007) [Pubmed]
  35. Chronic estradiol treatment improves brain homeostasis during aging in female rats. Alonso, A., Moreno, M., Ordóñez, P., Fernández, R., Pérez, C., Díaz, F., Navarro, A., Tolivia, J., González, C. Endocrinology (2008) [Pubmed]
  36. Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Gao, Q., Mezei, G., Nie, Y., Rao, Y., Choi, C.S., Bechmann, I., Leranth, C., Toran-Allerand, D., Priest, C.A., Roberts, J.L., Gao, X.B., Mobbs, C., Shulman, G.I., Diano, S., Horvath, T.L. Nat. Med. (2007) [Pubmed]
  37. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Fan, S., Wang, J., Yuan, R., Ma, Y., Meng, Q., Erdos, M.R., Pestell, R.G., Yuan, F., Auborn, K.J., Goldberg, I.D., Rosen, E.M. Science (1999) [Pubmed]
  38. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Anzick, S.L., Kononen, J., Walker, R.L., Azorsa, D.O., Tanner, M.M., Guan, X.Y., Sauter, G., Kallioniemi, O.P., Trent, J.M., Meltzer, P.S. Science (1997) [Pubmed]
  39. The impact of estradiol on bone mineral density is modulated by the specific estrogen receptor-alpha cofactor retinoblastoma-interacting zinc finger protein-1 insertion/deletion polymorphism. Grundberg, E., Akesson, K., Kindmark, A., Gerdhem, P., Holmberg, A., Mellström, D., Ljunggren, O., Orwoll, E., Mallmin, H., Ohlsson, C., Brändström, H. J. Clin. Endocrinol. Metab. (2007) [Pubmed]
  40. Estradiol acts directly on bone marrow myeloid progenitors to differentially regulate GM-CSF or Flt3 ligand-mediated dendritic cell differentiation. Carreras, E., Turner, S., Paharkova-Vatchkova, V., Mao, A., Dascher, C., Kovats, S. J. Immunol. (2008) [Pubmed]
  41. Variation in estrogen-related genes associated with cardiovascular phenotypes and circulating estradiol, testosterone, and dehydroepiandrosterone sulfate levels. Peter, I., Kelley-Hedgepeth, A., Fox, C.S., Cupples, L.A., Huggins, G.S., Housman, D.E., Karas, R.H., Mendelsohn, M.E., Levy, D., Murabito, J.M. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  42. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. Richelson, L.S., Wahner, H.W., Melton, L.J., Riggs, B.L. N. Engl. J. Med. (1984) [Pubmed]
  43. Bone mineral content of amenorrheic and eumenorrheic athletes. Drinkwater, B.L., Nilson, K., Chesnut, C.H., Bremner, W.J., Shainholtz, S., Southworth, M.B. N. Engl. J. Med. (1984) [Pubmed]
  44. Vitellogenin gene expression in male Xenopus hepatocytes during primary and secondary stimulation with estrogen in cell cultures. Searle, P.F., Tata, J.R. Cell (1981) [Pubmed]
  45. A randomized trial of chemotherapy and hormonal therapy in advanced breast cancer. Kiang, D.T., Gay, J., Goldman, A., Kennedy, B.J. N. Engl. J. Med. (1985) [Pubmed]
  46. Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Interventions Trial. Langer, R.D., Pierce, J.J., O'Hanlan, K.A., Johnson, S.R., Espeland, M.A., Trabal, J.F., Barnabei, V.M., Merino, M.J., Scully, R.E. N. Engl. J. Med. (1997) [Pubmed]
WikiGenes - Universities